Osiris Therapeutics (OSIR) researches, develops, manufactures, markets, and distributes regenerative medicine products.
OSIR products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chronic wounds, venous leg ulcers, and burns; BIO4, a bone allograft for use in all surgical applications, including spine, trauma, extremity, cranial, and foot and ankle surgery; and Cartiform, a viable chondral allograft that promotes articular cartilage repair to treat focal chondral defects.
Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.
- September 11, 2018 - 1:18pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q2
- June 7, 2018 - 9:59am | Out and About, Research Notes
- June 2, 2018 - 7:11am | Out and About, Out and About, Earnings, Earnings Q1
- March 10, 2018 - 9:22am | Earnings, Earnings Q4
- March 4, 2018 - 11:11am | Analysis, Out and About
- November 3, 2017 - 1:08pm | Earnings, Earnings Q3
- May 5, 2017 - 8:59am | Earnings, Earnings Q1
- March 10, 2017 - 12:00am | Earnings, Earnings Q4
- February 7, 2017 - 12:42pm | Research Notes
- November 2, 2016 - 8:46pm | Earnings, Earnings Q3
- August 4, 2016 - 10:50pm | Earnings, Earnings Q2
- June 24, 2016 - 12:48pm | Research Notes
- February 3, 2016 - 5:07pm | BOD & C-Suite Updates
- February 2, 2016 - 8:45am | Research Notes
- January 5, 2016 - 10:36am | Regulatory
- December 8, 2015 - 8:57am | Research Notes
- November 16, 2015 - 10:34am | Earnings Q3
- November 4, 2015 - 8:33am | Research Notes
- November 2, 2015 - 9:02am | Research Notes
- October 6, 2015 - 10:37am | Research Notes, Regulatory